These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29861178)

  • 21. Antibodies to Influenza Virus Hemagglutinin in the 2016/2017 Epidemic Season in Poland.
    Hallmann-Szelińska E; Cieślak K; Kowalczyk D; Szymański K; Brydak LB
    Adv Exp Med Biol; 2018; 1108():69-74. PubMed ID: 29931564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
    Islam S; Mohn KG; Krammer F; Sanne M; Bredholt G; Jul-Larsen Å; Tete SM; Zhou F; Brokstad KA; Cox RJ
    Vaccine; 2017 Oct; 35(42):5666-5673. PubMed ID: 28899626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yeast expressed recombinant Hemagglutinin protein of novel H1N1 elicits neutralising antibodies in rabbits and mice.
    Athmaram TN; Saraswat S; Santhosh SR; Singh AK; Suryanarayana WS; Priya R; Gopalan N; Parida M; Rao PV; Vijayaraghavan R
    Virol J; 2011 Nov; 8():524. PubMed ID: 22126628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and safety of H1N1 influenza hemagglutinin protein expressed in a baculovirus system.
    Na HN; Kim KH; Song MK; Park HL; Lee EY; Shim SH; Park S; Nam JH
    Microbiol Immunol; 2013 Sep; 57(9):660-4. PubMed ID: 23822120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody responses to influenza a H1N1 vaccine compared to the circulating strain in influenza vaccine recipients during the 2013/2014 season in North America.
    Barron MA; Frank DN; Claypool D; Ir D; Ning MF; Curtis D; Weinberg A
    J Clin Virol; 2016 Oct; 83():56-60. PubMed ID: 27591557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season.
    Gouma S; Zost SJ; Parkhouse K; Branche A; Topham DJ; Cobey S; Hensley SE
    Clin Infect Dis; 2020 Sep; 71(6):1447-1453. PubMed ID: 31598646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses.
    Boonsathorn N; Panthong S; Koksunan S; Chittaganpitch M; Phuygun S; Waicharoen S; Prachasupap A; Sasaki T; Kubota-Koketsu R; Yasugi M; Ono K; Arai Y; Kurosu T; Sawanpanyalert P; Ikuta K; Watanabe Y
    Biochem Biophys Res Commun; 2014 Sep; 452(3):865-70. PubMed ID: 25204499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly sensitive electrochemical biosensor based on redox - active monolayer for detection of anti-hemagglutinin antibodies against swine-origin influenza virus H1N1 in sera of vaccinated mice.
    Mikuła E; Silva CE; Kopera E; Zdanowski K; Radecki J; Radecka H
    BMC Vet Res; 2018 Nov; 14(1):328. PubMed ID: 30400888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1)pdm09 Viruses After Influenza Vaccination in Adults.
    Liu F; Tzeng WP; Horner L; Kamal RP; Tatum HR; Blanchard EG; Xu X; York I; Tumpey TM; Katz JM; Lu X; Levine MZ
    J Infect Dis; 2018 Oct; 218(10):1571-1581. PubMed ID: 29931203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
    Broecker F; Liu STH; Sun W; Krammer F; Simon V; Palese P
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulation of Influenza Virus in the 2015/2016 Epidemic Season in Poland: Serological Evaluation of Anti-hemagglutinin Antibodies.
    Kowalczyk D; Szymański K; Cieślak K; Hallmann-Szelińska E; Brydak LB
    Adv Exp Med Biol; 2019; 1150():77-82. PubMed ID: 30276725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses.
    Shembekar N; Mallajosyula VV; Malik A; Saini A; Varadarajan R; Gupta SK
    Monoclon Antib Immunodiagn Immunother; 2016 Aug; 35(4):191-8. PubMed ID: 27463230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus.
    Loeffen WL; de Vries RP; Stockhofe N; van Zoelen-Bos D; Maas R; Koch G; Moormann RJ; Rottier PJ; de Haan CA
    Vaccine; 2011 Feb; 29(8):1545-50. PubMed ID: 21219983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination.
    Subbramanian RA; Basha S; Shata MT; Brady RC; Bernstein DI
    Vaccine; 2010 Dec; 28(52):8258-67. PubMed ID: 21050903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
    Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.
    Xu L; Bao L; Lau SY; Wu WL; Yuan J; Gu S; Li F; Lv Q; Xu Y; Pushko P; Chen H; Qin C
    Vaccine; 2016 May; 34(23):2627-33. PubMed ID: 27083426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection.
    Walters KA; Zhu R; Welge M; Scherler K; Park JK; Rahil Z; Wang H; Auvil L; Bushell C; Lee MY; Baxter D; Bristol T; Rosas LA; Cervantes-Medina A; Czajkowski L; Han A; Memoli MJ; Taubenberger JK; Kash JC
    mBio; 2019 May; 10(3):. PubMed ID: 31088926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays.
    Huang JW; Lin WF; Yang JM
    Vaccine; 2012 Sep; 30(44):6327-37. PubMed ID: 22885274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.